TRANDATE Drug Patent Profile
✉ Email this page to a colleague
When do Trandate patents expire, and what generic alternatives are available?
Trandate is a drug marketed by Sebela Ireland Ltd, Alvogen, and Glaxosmithkline. and is included in three NDAs.
The generic ingredient in TRANDATE is hydrochlorothiazide; labetalol hydrochloride. Additional details are available on the hydrochlorothiazide; labetalol hydrochloride profile page.
US Patents and Regulatory Information for TRANDATE
International Patents for TRANDATE
See the table below for patents covering TRANDATE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 280996 | ⤷ Start Trial | |
| Austria | 300763 | ⤷ Start Trial | |
| Belgium | 704037 | ⤷ Start Trial | |
| Belgium | 752892 | ⤷ Start Trial | |
| Canada | 932734 | PHENYLAMINOETHANOL DERIVATIVES | ⤷ Start Trial |
| Canada | 983524 | PHENYLAMINOETHANOL DERIVATIVES | ⤷ Start Trial |
| Switzerland | 492676 | Verfahren zur Herstellung von 1-Phenyl-2-aminoäthanol-Derivaten | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
